Drug Name Drug
Found 7 free book(s)
2022 CIGNA COMPREHENSIVE DRUG LIST (Formulary)
www.cigna.comOct 01, 2021 · a brand name drug currently on the drug list; or add new restrictions to the brand name drug or move it to a different cost-sharing tier or both. Or we may make changes based on new clinical guidelines and/or studies. If we remove drugs from our drug list, add prior authorization, quantity limits, and/
Preferred Drug List - BCBSM
www.bcbsm.comGeneric drug substitution occurs when a pharmacist dispenses a generic equivalent in place of the brand-name product. Generic substitution is required for most Blue Cross and BCN members. If both the generic and brand names are on the drug list, the drug is assigned to the tier that matches the available generic. The brand-name drug is
Select Drug Formulary - AmeriHealth
www.amerihealth.com• Generally, if a brand-name drug has a generic equivalent, the brand-name drug is non-preferred while the generic equivalent is covered at the generic level of cost-sharing. ®For example: Cipro is the brand drug and is considered non-preferred; its generic equivalent ciprofloxacin is available at the generic level of cost-sharing.
DRUG FORMULARY - Government of New York
www.wcb.ny.govA brand name drug when a generic version with the same active ingredient(s) is commercially available in a different strength/dosage (e.g., a generic drug available in 5 mg and 10 mg, but brand name drug available in 7.5 mg would be considered non-formulary and could only
DRUG NAME: Methotrexate - BC Cancer
www.bccancer.bc.caDRUG NAME: Methotrexate SYNONYM(S): amethopterin,1 MTX COMMON TRADE NAME(S): CLASSIFICATION: antimetabolite Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Methotrexate is a folate antagonist.2 Tetrahydrofolate is the active form of folic acid required for purine and thymidylate ...
DRUG NAME: Nivolumab
www.bccancer.bc.caDRUG NAME: Nivolumab SYNONYM(S): COMMON TRADE NAME(S): OPDIVO® CLASSIFICATION: immunotherapy. Special pediatric considerations are noted when applicable, otherwise adult provisions apply. MECHANISM OF ACTION: Nivolumab is a fully human IgG4 monoclonal antibody known as a programmed cell death 1 (PD-1) immune checkpoint inhibitor.
DRUG USE QUESTIONNAIRE (DAST-20) Name: Date: The …
adai.uw.eduDRUG USE QUESTIONNAIRE (DAST-20) Name: _____ Date: _____ The following questions concern information about your potential involvement with drugs not including alcoholic beverages during the past 12 months. Carefully read each statement and decide if …